At close: December 13 at 4:00:01 PM EST
After hours: 7:56:39 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-50,940.0000
-70,453.0000
-94,779.0000
-59,832.0000
-23,750.0000
Investing Cash Flow
-16,623.0000
43,952.0000
-20,415.0000
-49,097.0000
-1,220.0000
Financing Cash Flow
56,360.0000
15,243.0000
17,462.0000
125,804.0000
138,314.0000
End Cash Position
22,035.0000
34,755.0000
46,013.0000
143,745.0000
126,870.0000
Capital Expenditure
-406.0000
-1,871.0000
-9,601.0000
-5,157.0000
-1,223.0000
Issuance of Capital Stock
56,289.0000
15,030.0000
17,237.0000
122,210.0000
111,109.0000
Free Cash Flow
-51,346.0000
-72,324.0000
-104,380.0000
-64,989.0000
-24,973.0000
12/31/2020 - 12/11/1981
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
INO Inovio Pharmaceuticals, Inc.
2.3200
-38.30%
IBIO iBio, Inc.
2.3100
-7.97%
SRNE Sorrento Therapeutics, Inc.
0.0015
+25.00%
OCGN Ocugen, Inc.
0.8574
+0.59%
TNXP Tonix Pharmaceuticals Holding Corp.
0.2405
+5.07%
NVAX Novavax, Inc.
9.11
+1.00%
JAGX Jaguar Health, Inc.
0.9693
-0.59%
ALT Altimmune, Inc.
9.03
+5.12%
GOVX GeoVax Labs, Inc.
2.3500
-2.08%
BLUE bluebird bio, Inc.
6.34
-16.58%